Overview
Financials
The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-02-01. Active
07 1050 1953 1000 0090 8109 2612- 74 1050 1953 1000 0090 8109 0921
- 82 1050 1953 1000 0090 8109 2620
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 16, 2020 | Aid for research and development projects: industrial research | $2.1M$2,060,697 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 16, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $97,577$97,577 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 16, 2020 | Aid for research and development projects: experimental development | $88,436$88,436 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-01 | Opracowanie i przetestowanie innowacyjnej technologii wytwarzania specyficznych przeciwciał oraz urządzenia do szybkiej diagnostyki wirusów, w tym SARS-CoV-2, możliwej do wdrożenia w obszarze diagnostyki, terapii i prewencji w stanach zagrożenia epidemiologicznego | $2.6M$2,599,409 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 579 | $7,820.10 | 82.7143% | |
Others | 121 | $1,634.25 | 17.2857% |
Manner of representation
In the event of the appointment of a multi-member management board, declarations of will on behalf of the company shall be made by all members of the management board acting jointly.
Beneficial owners
| Person | Rights | |
|---|---|---|
Sagan Mateusz (48)  | Shareholder of a limited liability company, 2000.0 PLN | |
Magdalena Staniszewska (52) | Shareholder of a limited liability company, 2000.0 PLN | |
Marcin Staniszewski (53) | Prezes zarządu sds optic s.a. - wspólnika posiadającego 79,1% udziałów w fibiomed sp. z o.o. | |
Marcin Staniszewski (53) | Shareholder of a limited liability company, 2050.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| Zakład Genetyki Sądowejsp. z o.o. | $727,654.12 | dna-zgs.pl | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| Microbe Plussp. z o.o. | $104,197.26 | microbe-plus.com | ||
| Vitagenumsp. z o.o. | $9,376.94 | vitagenum.pl | ||
| Meritrosp. z o.o. | $7,890.74 | meritro.com | ||
| Dairy Biotechnologiessp. z o.o. | $1,485.09 | milcu.eu | ||
| ImmunotronicsP.S.A. | $0.16 | immunotronics.net | ||
| Aiventrosp. z o.o. | $0.00 | aiventro.com | ||
| Walletmed Heartsp. z o.o. | — | walletmed.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-07-04 | Share capital change (29,000.00 PLN → 35,000.00 PLN) | |
| 2021-09-27 | Share capital change (5,000.00 PLN → 29,000.00 PLN) | |
| 2021-03-26 | Address change (Ul. Fryderyka Chopina 41/2, 20-023, Lublin → Ul. Głęboka 39, 20-612, Lublin) | |
| 2020-07-14 | Entered in the register |
FAQ
Last updated: 2026-04-30